Pitney Bowes [PBI] vs Cryoport [CYRX] Detailed Stock Comparison
Pitney Bowes
NYSE
Loading...
Cryoport
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pitney Bowes wins in 12 metrics, Cryoport wins in 5 metrics, with 0 ties. Pitney Bowes appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pitney Bowes | Cryoport | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.13 | -3.60 | Cryoport |
| Price-to-Book Ratio | N/A | 0.90 | N/A |
| Debt-to-Equity Ratio | -3.77 | 44.34 | Pitney Bowes |
| PEG Ratio | 11.30 | 0.02 | Cryoport |
| EV/EBITDA | 9.75 | -11.06 | Cryoport |
| Profit Margin (TTM) | -5.60% | 31.67% | Cryoport |
| Operating Margin (TTM) | 15.47% | -21.23% | Pitney Bowes |
| EBITDA Margin (TTM) | 15.47% | N/A | N/A |
| Return on Equity | 35.20% | -9.19% | Pitney Bowes |
| Return on Assets (TTM) | 4.47% | -4.21% | Pitney Bowes |
| Free Cash Flow (TTM) | $156.77M | $-37.59M | Pitney Bowes |
| Dividend Yield | 1.54% | N/A | N/A |
| 1-Year Return | 60.16% | 1.24% | Pitney Bowes |
| Price-to-Sales Ratio (TTM) | 0.99 | 1.79 | Pitney Bowes |
| Enterprise Value | $3.67B | $266.39M | Pitney Bowes |
| EV/Revenue Ratio | 1.86 | 1.12 | Cryoport |
| Gross Profit Margin (TTM) | 53.59% | 47.03% | Pitney Bowes |
| Revenue per Share (TTM) | $11 | $5 | Pitney Bowes |
| Earnings per Share (Diluted) | $0.80 | $-1.00 | Pitney Bowes |
| Beta (Stock Volatility) | 1.52 | 1.88 | Pitney Bowes |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pitney Bowes vs Cryoport Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pitney Bowes | 4.60% | 4.79% | -7.58% | 18.67% | 11.40% | 63.71% |
| Cryoport | 5.53% | 4.18% | 20.73% | 44.21% | 41.71% | 12.41% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pitney Bowes | 60.16% | 287.54% | 102.40% | -40.75% | -39.72% | -72.17% |
| Cryoport | 1.24% | -76.18% | -83.84% | 210.38% | 6.79% | -98.81% |
Performance & Financial Health Analysis: Pitney Bowes vs Cryoport
| Metric | PBI | CYRX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.94B | $425.57M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,867,110 | 690,640 |
| 90 Day Avg. Volume | 3,908,483 | 879,583 |
| Last Close | $11.82 | $8.97 |
| 52 Week Range | $6.22 - $13.11 | $4.58 - $9.48 |
| % from 52W High | -9.84% | -5.38% |
| All-Time High | $73.31 (Apr 26, 1999) | $768.00 (Nov 21, 2005) |
| % from All-Time High | -83.88% | -98.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | 0.15% |
| Quarterly Earnings Growth | -0.42% | -0.21% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.32% |
| Operating Margin (TTM) | 0.15% | -0.21% |
| Return on Equity (TTM) | 0.35% | -0.09% |
| Debt to Equity (MRQ) | -3.77 | 44.34 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-3.06 | $9.49 |
| Cash per Share (MRQ) | $1.75 | $8.51 |
| Operating Cash Flow (TTM) | $243.93M | $-16,720,000 |
| Levered Free Cash Flow (TTM) | $229.59M | $-11,699,250 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.54% | N/A |
| Last 12-Month Dividend | $0.16 | N/A |
Valuation & Enterprise Metrics Analysis: Pitney Bowes vs Cryoport
| Metric | PBI | CYRX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.13 | -3.60 |
| Forward P/E | 11.30 | -8.76 |
| PEG Ratio | 11.30 | 0.02 |
| Price to Sales (TTM) | 0.99 | 1.79 |
| Price to Book (MRQ) | N/A | 0.90 |
| Market Capitalization | ||
| Market Capitalization | $1.94B | $425.57M |
| Enterprise Value | $3.67B | $266.39M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.86 | 1.12 |
| Enterprise to EBITDA | 9.75 | -11.06 |
| Risk & Other Metrics | ||
| Beta | 1.52 | 1.88 |
| Book Value per Share (MRQ) | $-3.06 | $9.49 |
Financial Statements Comparison: Pitney Bowes vs Cryoport
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PBI | CYRX |
|---|---|---|
| Revenue/Sales | $493.42M | $41.04M |
| Cost of Goods Sold | $224.30M | $22.40M |
| Gross Profit | $269.12M | $18.64M |
| Research & Development | $4.76M | $3.93M |
| Operating Income (EBIT) | $96.59M | $-9.48M |
| EBITDA | $100.73M | $-2.14M |
| Pre-Tax Income | $46.73M | $-8.79M |
| Income Tax | $11.31M | $234,000 |
| Net Income (Profit) | $35.42M | $-11.98M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PBI | CYRX |
|---|---|---|
| Cash & Equivalents | $323.79M | $36.10M |
| Total Current Assets | $1.18B | $411.28M |
| Total Current Liabilities | $1.49B | $74.03M |
| Long-Term Debt | $2.00B | $224.19M |
| Total Shareholders Equity | $-535.88M | $398.81M |
| Retained Earnings | $2.65B | $-769.16M |
| Property, Plant & Equipment | $342.09M | $119.58M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PBI | CYRX |
|---|---|---|
| Operating Cash Flow | $94.41M | $-6.40M |
| Capital Expenditures | N/A | $-3.17M |
| Free Cash Flow | $-33.57M | $-8.42M |
| Debt Repayment | $-787.19M | $-192,000 |
| Common Stock Repurchase | $-15.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PBI | CYRX |
|---|---|---|
| Shares Short | 12.09M | 2.91M |
| Short Ratio | 3.65 | 6.87 |
| Short % of Float | 0.09% | 0.07% |
| Average Daily Volume (10 Day) | 2,867,110 | 690,640 |
| Average Daily Volume (90 Day) | 3,908,483 | 879,583 |
| Shares Outstanding | 182.41M | 49.91M |
| Float Shares | 157.75M | 43.33M |
| % Held by Insiders | 0.01% | 0.04% |
| % Held by Institutions | 0.76% | 1.01% |
Dividend Analysis & Yield Comparison: Pitney Bowes vs Cryoport
| Metric | PBI | CYRX |
|---|---|---|
| Last 12-Month Dividend | $0.16 | N/A |
| Last 12-Month Dividend Yield | 1.54% | N/A |
| 3-Year Avg Annual Dividend | $0.17 | N/A |
| 3-Year Avg Dividend Yield | 1.10% | N/A |
| 3-Year Total Dividends | $0.51 | N/A |
| Ex-Dividend Date | Feb 21, 2025 | N/A |